ClearPoint Neuro, Inc. (CLPT)
NASDAQ: CLPT · Real-Time Price · USD
14.94
+0.36 (2.47%)
Jul 31, 2026, 4:00 PM EDT - Market closed
ClearPoint Neuro Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 35.59 | 45.92 | 20.1 | 23.14 | 27.62 | 54.11 |
Short-Term Investments | - | - | - | - | 9.87 | - |
Cash & Short-Term Investments | 35.59 | 45.92 | 20.1 | 23.14 | 37.49 | 54.11 |
Cash Growth | 187.34% | 128.43% | -13.12% | -38.27% | -30.72% | 169.21% |
Accounts Receivable | 8.66 | 6.55 | 4.71 | 3.21 | 2.67 | 2.34 |
Inventory | 8.57 | 8.36 | 6.86 | 7.91 | 9.3 | 4.94 |
Other Current Assets | 2.05 | 2.77 | 1.68 | 1.91 | 1.72 | 0.51 |
Total Current Assets | 54.88 | 63.6 | 33.36 | 36.17 | 51.18 | 61.89 |
Net Property, Plant & Equipment | 16 | 11.05 | 5.09 | 4.95 | 2.7 | 2.78 |
Other Intangible Assets | 13.42 | 13.92 | - | - | - | - |
Goodwill | 7.47 | 7.47 | - | - | - | - |
Other Long-Term Assets | 1.65 | 1.7 | 0.74 | 1.54 | 1.61 | 0.91 |
Total Assets | 93.42 | 97.75 | 39.19 | 42.66 | 55.49 | 65.58 |
Accounts Payable | 2.33 | 1.26 | 1.34 | 0.39 | 0.27 | 0.43 |
Accrued Expenses | 5.1 | 7.15 | 6.34 | 4 | 4.89 | 3.14 |
Current Portion of Leases | 0.23 | 0.69 | 0.56 | 0.42 | 0.56 | 0.51 |
Unearned Revenue | 1.81 | 1.67 | 2.12 | 2.61 | 1.07 | 0.68 |
Total Current Liabilities | 9.48 | 10.77 | 10.35 | 7.43 | 6.79 | 4.75 |
Long-Term Debt | 49.64 | 49.08 | - | 9.95 | 9.89 | 9.84 |
Long-Term Leases | 13.71 | 8.46 | 3.01 | 3.57 | 1.53 | 1.94 |
Other Long-Term Liabilities | 1.74 | 0.94 | 0.44 | 0.54 | 0.39 | 0.26 |
Total Long-Term Liabilities | 65.1 | 58.47 | 3.45 | 14.06 | 11.82 | 12.04 |
Total Liabilities | 74.58 | 69.73 | 13.8 | 21.49 | 18.6 | 16.79 |
Common Stock | 0.3 | 0.29 | 0.28 | 0.25 | 0.25 | 0.24 |
Additional Paid-in Capital | 245 | 244.64 | 216.48 | 193.38 | 187.01 | 182.48 |
Retained Earnings | -226.46 | -216.91 | -191.37 | -172.46 | -150.37 | -133.93 |
Shareholders' Equity | 18.84 | 28.02 | 25.39 | 21.17 | 36.89 | 48.79 |
Total Liabilities & Equity | 93.42 | 97.75 | 39.19 | 42.66 | 55.49 | 65.58 |
Total Debt | 63.59 | 58.23 | 3.57 | 13.94 | 11.99 | 12.28 |
Net Cash (Debt) | -28 | -12.31 | 16.54 | 9.2 | 25.5 | 41.83 |
Net Cash Growth | - | - | 79.76% | -63.93% | -39.02% | - |
Net Cash Per Share | -0.97 | -0.43 | 0.61 | 0.37 | 1.05 | 2.02 |
Book Value | 18.84 | 28.02 | 25.39 | 21.17 | 36.89 | 48.79 |
Book Value Per Share | 0.65 | 0.99 | 0.94 | 0.86 | 1.53 | 2.35 |
Tangible Book Value | -2.05 | 6.63 | 25.39 | 21.17 | 36.89 | 48.79 |
Tangible Book Value Per Share | -0.07 | 0.23 | 0.94 | 0.86 | 1.53 | 2.35 |